← Back
$REGN All transactions

REGENERON PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

1,500

Price

$0

Filed

Jan 8

Insider

Name

Bassler Bonnie L

Title

CIK

0001683607

Roles

Director

Transaction Details

Transaction Date

2026-01-07

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,861

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 2, 2025. | Represents volume-weighted average price of sales of 1,500 shares of Company stock on January 7, 2026 at prices ranging from $800.00 to $800.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 7, 2026 at each separate price. | On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.

Filing Info

Accession No.

0001683607-26-000008

Form Type

4

Issuer CIK

0000872589

Bassler Bonnie L's History

Date Ticker Type Value
2026-03-31 RPRX A $37K
2026-01-07 CDTX D $3K
2026-01-07 CDTX D
2026-01-07 CDTX D
2026-01-07 CDTX D
2026-01-07 CDTX D
2026-01-07 CDTX D
2026-01-07 CDTX D
2026-01-07 CDTX D
2026-01-07 REGN M $561K

Other Insiders at REGN (90d)

Insider Bought Sold Last
RYAN ARTHUR F $234K 2026-04-01
Zoghbi Huda Y $1.3M 2026-02-19
Pitofsky Jason
SVP Controller
$1.6M 2026-02-09